Market News / Story
SXTP — Hospital study remains blinded; expanded access results and 2027 unblinding are next
Quartr ·
Quartr reports: The DSMB recommended completing the blinded hospital study, with no safety signal; follow-up of 30 patients is planned before unblinding in early 2027. The first three expanded access patients were reported cured, with two more outcomes expected in November. Based on 60 Degrees Pharmaceuticals, Inc. [SXTP] Study update Audio Transcript — Oct. 6 2026 This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.